Melissa Engle

Statistics

Publications

Citations

1.8K

H-Index

Active since

1997

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Centers for Disease Control and Prevention

Case Western Reserve University

South Texas Veterans Health Care System

University of California, San Francisco

Melissa Engle is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, pharmacokinetics, and tuberculosis pharmacotherapy.

Publications per year

1997–2024

Publications

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova et al. · New England Journal of Medicine · 2021 · 551 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis

William J. Burman, Stefan Goldberg, John L. Johnson et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 285 citations

Medicine, Pharmacology, Pharmacotherapy +13

Effects of Tuberculosis, Race, and Human Gene <i>SLCO1B1</i> Polymorphisms on Rifampin Concentrations

Marc Weiner, Charles A. Peloquin, William J. Burman et al. · Antimicrobial Agents and Chemotherapy · 2010 · 156 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Effects of Rifampin and Multidrug Resistance Gene Polymorphism on Concentrations of Moxifloxacin

Marc Weiner, William J. Burman, Chi-Cheng Luo et al. · Antimicrobial Agents and Chemotherapy · 2007 · 106 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials

RM Savic, Marc Weiner, Melissa Engle et al. · Clinical Pharmacology & Therapeutics · 2017 · 86 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 18